Repligen (RGEN) Cash from Investing Activities (2010 - 2026)
Repligen's (RGEN) quarterly Cash from Investing Activities came in at -$4.0 million in Q1 2026, up 94.62% year-on-year from -$2.0 million in Q1 2025, and up 98.09% on a QoQ basis from -$208.7 million in Q4 2025.
Repligen (RGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Cash from Investing Activities data on file, last reported at -$4.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 94.62% year-over-year to -$4.0 million in Q1 2026; TTM through Mar 2026 was -$228.4 million, a 50.11% decrease from a year earlier, with the FY2025 full-year figure at -$298.5 million, down 245.52% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$4.0 million, up from -$208.7 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for RGEN reached as high as $64.8 million in Q2 2023 and fell as low as -$208.7 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged -$43.8 million across 5 years, with a median of -$9.4 million in 2023.
- Across the five-year window, Cash from Investing Activities soared 347.27% in 2023 and tumbled 786.25% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$121.3 million in 2022, then slumped by 40.06% to -$169.9 million in 2023, then jumped by 61.88% to -$64.8 million in 2024, then sank by 222.32% to -$208.7 million in 2025, then jumped by 98.09% to -$4.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$4.0 million in Q1 2026, -$208.7 million in Q4 2025, and -$7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Repligen | 7.37 Bn | 6.39 Bn | 108.28 Mn | -3.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.99 Mn |
| Mar 31, 2026 | -3.99 Mn |
| Dec 31, 2025 | -208.74 Mn |
| Dec 31, 2025 | -208.74 Mn |
| Sep 30, 2025 | -7.78 Mn |
| Sep 30, 2025 | -7.78 Mn |
| Jun 30, 2025 | -7.84 Mn |
| Jun 30, 2025 | -7.84 Mn |
| Mar 31, 2025 | -74.11 Mn |
| Mar 31, 2025 | -74.11 Mn |
| Dec 31, 2024 | -64.76 Mn |
| Dec 31, 2024 | -64.76 Mn |
| Sep 30, 2024 | -5.86 Mn |
| Sep 30, 2024 | -5.86 Mn |
| Jun 30, 2024 | -7.40 Mn |
| Jun 30, 2024 | -7.40 Mn |
| Mar 31, 2024 | -8.36 Mn |
| Mar 31, 2024 | -8.36 Mn |
| Dec 31, 2023 | -169.91 Mn |
| Dec 31, 2023 | -169.91 Mn |